Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hikma MENA
London, United Kingdomhikma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Hikma is a commercial-stage pharmaceutical company with over 800 products marketed globally, including branded generics, generic injectables, and biosimilars
- Therapeutic areas
- CardiovascularOncologyInfectious DiseasesEndocrinology
- Modalities
- Small moleculeBiologicAntibodyBiosimilar
- Industry
- Biotech
02
Partnerships
Celltrion HealthcareTakeda Pharmaceuticals InternationalGuardant HealthRakuten MedicalSK BPBoehringer Ingelheim
Beyond the preview
Go deeper on Hikma MENA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hikma MENA.